Thyrocare Q2 results: Profit falls 68% as ₹45 crore impairment charge weighs on earnings

Revenue rose 25.1% year-on-year to ₹271 crore from ₹217 crore, while EBITDA increased 25.1% to ₹89 crore from ₹71 crore. The EBITDA margin remained flat at 33% year-on-year.